Neurogene (NGNE) Intangibles (2019 - 2022)

Neurogene (NGNE) reported Intangibles of $18000.0 for Q2 2022, down 92.44% on a YoY basis from $238000.0 in Q2 2021, and down 75.34% quarter-over-quarter from $73000.0 in Q1 2022.

Neurogene (NGNE) Intangibles (2019 - 2022) Analysis & Trends

Neurogene has reported Intangibles for 4 years, with the latest figure at $18000.0 in Q2 2022.

  • For the quarter ending Q2 2022, Intangibles fell 92.44% year-over-year to $18000.0; the trailing twelve-month figure through Jun 2022 stood at $18000.0 (down 92.44% YoY), and the FY2021 full-year result was $128000.0, down 63.11% from the prior year.
  • Intangibles for Q2 2022 stood at $18000.0, down from $73000.0 in the prior quarter.
  • The five-year high for Intangibles was $622000.0 in Q3 2019, with the low at $18000.0 in Q2 2022.
  • Historically, Intangibles has averaged $320250.0 across 4 years, with a median of $320000.0 in 2020.
  • Annual changes were most pronounced in 2020 — Intangibles tumbled 35.21% — and 2022, when it sank 92.44%.
  • Neurogene's Intangibles stood at $567000.0 in 2019, then sank by 38.8% to $347000.0 in 2020, then tumbled by 63.11% to $128000.0 in 2021, then slumped by 85.94% to $18000.0 in 2022.
  • The last three Intangibles figures came in at $18000.0 (Q2 2022), $73000.0 (Q1 2022), and $128000.0 (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4.41 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 30.30 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 418.50 Mn
9 Abivax 91.96 Bn 91.96 Bn - 7.73 Mn
10 Neurogene 216.17 Mn 216.17 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 18,000.00
Mar 31, 2022 73,000.00
Dec 31, 2021 128,000.00
Sep 30, 2021 183,000.00
Jun 30, 2021 238,000.00
Mar 31, 2021 293,000.00
Dec 31, 2020 347,000.00
Sep 30, 2020 403,000.00
Jun 30, 2020 458,000.00
Mar 31, 2020 513,000.00
Dec 31, 2019 567,000.00
Sep 30, 2019 622,000.00